Keynote Speaker Interacts with Holographic Self at Life Sciences Conference
TORONTO, June 26, 2018 (GLOBE NEWSWIRE) -- ARHT Media Inc. (“ARHT” or “the Company”) (TSXV:ART), a global leader in the development, production and distribution of high quality hologram content through its patented Augmented Reality Holographic Telepresence technology, in partnership with Centrifuge Media kicked-off the Life Sciences Trainers and Educators Network Conference (“L-TEN”) in Phoenix, AZ, with President David Fortanbary appearing on stage as a hologram. Audience members from around the country were welcomed by the holographic president and then surprised when Fortanbary, in person, took the stage to interact with his own hologram. Showcased on ARHT’s portable H10 Display, the holographic Fortanbary was able to appear on stage without disrupting the conferences show flow or speakers – including himself. ARHT’s ability to capture and playback photo-realistic human holograms delighted guests and elevated the keynote address.
“We are always looking for new and innovative ways to engage with attendees on stage. ARHT Media’s holographic technology was the perfect introduction to the President and Keynote, but also a unique and memorable way to kick-off L-TEN 2018 overall,” says Chris Spohr, Agency Director of Centrifuge Media.
“Our quality photo-realistic holograms paired with the H10 Display’s minimal stage footprint was perfect for an event like L-TEN’s,” added ARHT Media CEO Larry O’Reilly. “We love when our clients have fun with the technology and the interaction between the two David’s was a hit. Our technology’s scalability and ease-of-use has definitely made an impact on the conferences and meeting planner industry.”
Watch the event footage here https://vimeo.com/276286653
About ARHT Media
ARHT’s patented Augmented Reality Holographic Telepresence technology is the world’s first complete end-to-end solution for the creation, transmission, and delivery of lifelike digital holograms. The company's technology is protected by U.S. Patent No. 9,581,962.
Connect with ARHT Media
Twitter: http://www.twitter.com/ARHTmedia
Facebook: http://www.facebook.com/ARHTmediainc
LinkedIn: http://www.linkedin.com/company/arht-media-inc-
For more information, please visit http://www.arhtmedia.com/ or contact the investor relations group at info@arhtmedia.com.
ARHT Media trades under the symbol “ART” on the Toronto Venture Stock Exchange.
ARHT Investor Contact:
Ali Mahdavi
am@spinnakercmi.com
ARHT Media Press Contact:
Salman Amin
samin@arhtmedia.com
This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, the Company’s technology; the potential uses for the Company’s technology; the future planned events using the Company’s technology; the future success of the Company; the ability of the Company to monetize the HumaGram™ technology; the development of the Company’s technology participation by the Company in the Life Sciences Conference; and interest from parties in ARHT’s products. Generally, forward looking information can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information, including but not limited to: general business, economic and competitive uncertainties; regulatory risks; risks inherent in technology operations; and other risks of the technology industry. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
© 2018 GlobeNewswire, Inc. All Rights Reserved.
Regeneron Pharmaceuticals' (Nasdaq: REGN) REGEN-COV2 is First Antibody Cocktail for COVID-19 to Receive FDA Emergency Use Authorization
